Gómez-Pue D, Olaya-Guzmán EJ, Marquez-Acosta G, Jimenez-López J, Durán-Boullosa E, Reyes-Muñoz E, Arteaga-Gómez AC

Language: Spanish
References: 20
Page: 631-636
PDF size: 203.84 Kb.

ABSTRACT

Endometrial cancer is one of the most common gynecological malignancies. The mean age at diagnosis is in the sixth decade of life, up to 25% of endometrial cancer cases occur in premenopausal women, and between 2.5 and 14.4% of the cases involve patients younger than 40 years. The standard treatment for patients with endometrial cancer is hysterectomy and salpingo-oophorectomy as part of the staging surgery. There are several studies that reported various cases of successful conservative treatment, achieving complete response, using hormonal therapy with progesterone in young women with desire of childbearing that meet strict criteria such as endometrioid type of endometrial cancer, low grade disease, no evidence of myometrial or metastatic disease on ultrasound or MRI and accepting and facilitate strict surveillance. The fertility-preserving treatment of endometrial cancer is not standard worldwide, the available evidence suggest that this is a feasible and safe option for a group of selected patients.

REFERENCES

1. International Agency for Reserch on Cancer. WHO. Cancer Incidence and Mortality World Wide in 2008.

2. Chiva L, Lapuente F, González-Cortijo L, Carballo N, et al. Sparing fertility in young patients with endometrial cáncer. Gynecologic Oncology 2008;111:S101-S104.

3. Prasong T, Thanyarat W. Challenging Regimen for Long-Term Conservative Treatment of Endometrial Adenocarcinoma in Young Women: A Case Report and Review of the Literature. Case Rep Oncol 2010;3:380-385.

4. Ramirez PT, Frumovitz M, Bodurka DC, Sun CC, Levenback C. Hormonal therapy for the management of grade 1 endometrial adenocarcinoma: a literature review. Gynecologic Oncology 2004;95:133-138.

5. Kalogiannidis I, Agorastos T. Conservative management of young patients with endometrial highly-differentiated adenocarcinoma. Journal of Obstetrics and Gynaecology 2011;31(1):13-17.

6. Erkanli S, Ayhan A. Fertility-Sparing Therapy in Young Women With Endometrial Cancer 2010 Update. Int J Gynecol Cancer 2010;20:1170-1187.

7. Larson DM, Johnson KK, Broste SK, et al. Comparison of D&C and office endometrial biopsy in predicting final histopathologic grade in endometrial cancer. Obstet Gynecol 1995;86:38-42.

8. Clark TJ, Voit D, Gupta JK, et al. Accuracy of hysteroscopy in the diagnosis of endometrial cancer and hyperplasia: a systematic quantitative review. JAMA 2002;288:1610-1621.

9. Kinkel K, Kaji Y, Yu KK et al. Radiologic staging in patients with endometrial cancer: a metaanalysis. Radiology 1999;212:711-718.

10. Saez F, Urresola A, Larena JA, Martin JI, Pijuan JI, et al: Endometrial carcinoma: assessment of myometrial invasion with plain and gadolinium-enhanced MR imaging. J Magn Reson Imaging 2000;12:460-466.

11. Taieb S, Ceugnart L, Leblanc E, et al. MR imaging of endometrial carcinoma: role and limits. Bull Cancer 2002;89:963-968.

12. Morice P, Fourchotte V, Sideris L, et al. A need for laparoscopic evaluation of patients with endometrial carcinoma selected for conservative treatment. Gynecol Oncol 2005;96:245-248.

13. Kitajima K, Murakami K, Kaji Y, Sakamoto S, Sugimura K. Established, emerging and future applications of FDG-PET/ CT in the uterine cancer. Clin Radiol 2011;66(4):297-307.

14. Fuentes Dehesa M, Arteaga Gomez A, Moreno verduzco E, Aranda Flores C. Embarazo después del tratamiento conservador del cáncer de endometrio. Ginecol Obstet Mex 2009;77(9):419-422.

15. Kaku T, Yoshikawa H, Tsuda H, et al. Conservative therapy for adenocarcinoma and atypical endometrial hyperplasia of the endometrium in young women: central pathologic review and treatment outcome. Cancer Lett 2001;167:39-48.

16. Dhar KK, NeedhiRajan T, Koslowski M, Woolas RP: Is levonorgestrel intrauterine system effective for treatment of early endometrial cancer? Report of four cases and review of the literature. Gynecol Oncol 2005;97:924-927.

17. Sparac V, Ujevi B, Ujevi M, et al. Successful pregnancy after hysteroscopic removal of grade I endometrial carcinoma in a young woman with Lynch syndrome. Int J Gynecol Cancer 2006;16 Suppl 1:442-445.

18. Mazzon I, Corrado G, Masciullo V, Morricone D, Ferrandina G, et al. Conservative surgical management of stage IA endometrial carcinoma for fertility preservation. Fertil Steril 2010;93:1286-1289.

19. Laurelli G, Di Vagno G, Scaffa C, Losito S, Del Giudice M, et al. Conservative treatment of early endometrial cancer: preliminary results of a pilot study. Gynecol Oncol 2011;120:43-46.

20. Park H, Seok JM, Yoon BS, Seong SJ, Kim JY, et al. Effectiveness of high-dose progestin and long-term outcomes in young women with early-stage, well-differentiated endometrioid adenocarcinoma of uterine endometrium. Arch Gynecol Obstet 2011;25. [Epub ahead of print]